MTOR and leiomyoma: The PI3K/Akt pathway participates in the regulation of mammalian target of rapamycin (mTOR), and modulates cancer cell survival, proliferation, and apoptosis, therefore playing an important role in cancer progression [24] and in leiomyoma [31].